# Numbering and Methods for Antibody Analysis
# 抗体分析编号与方法说明

## Numbering Scheme (编号方案)

### English
All antibody sequences in this report are analyzed using the **IMGT (International ImMunoGeneTics information system)** numbering scheme as the primary coordinate system. The IMGT scheme provides a standardized nomenclature for all vertebrate antigen receptor sequences, ensuring consistency in defining Framework Regions (FR) and Complementarity-Determining Regions (CDR) across different modalities, including conventional antibodies (VH/VL) and single-domain antibodies (VHH).

All structural references, including:
- **FR/CDR boundaries**: Defined strictly by IMGT positions (e.g., CDR1: 27-38, CDR2: 56-65, CDR3: 105-117).
- **Structural Anchors and Vernier Zones**: Mapped to IMGT coordinates.
- **VHH Hallmarks**: Identified at IMGT positions 37, 44, 45, and 47.
- **North–Dunbrack Canonical Classes**: Assigned based on IMGT-defined loop lengths and sequence motifs.

**Kabat numbering** is provided as a cross-reference only where historically relevant for comparison with legacy literature or specific engineering protocols. In all cases of conflict, IMGT coordinates shall be considered the authoritative source of truth for this report.

### 中文
本报告中的所有抗体序列均采用 **IMGT (International ImMunoGeneTics information system)** 编号方案作为首要坐标系统。IMGT 方案为所有脊椎动物抗原受体序列提供了标准化的命名法，确保了在常规抗体 (VH/VL) 和单域抗体 (VHH) 等不同模态中，框架区 (FR) 和互补决定区 (CDR) 定义的一致性。

所有结构参考指标均基于 IMGT 坐标定义，包括：
- **FR/CDR 边界**：严格由 IMGT 位置定义（例如：CDR1: 27-38, CDR2: 56-65, CDR3: 105-117）。
- **结构锚点 (Anchors) 与 Vernier 区**：映射至 IMGT 坐标。
- **VHH 特征位点 (Hallmarks)**：识别为 IMGT 位置 37, 44, 45 和 47。
- **North–Dunbrack 规范构型**：基于 IMGT 定义的环长度和序列基序进行分配。

**Kabat 编号** 仅在与传统文献或特定工程方案进行比较时作为交叉引用提供。在发生编号冲突的情况下，应以 IMGT 坐标作为本报告的权威溯源依据。

---
**Audit Trail**: Produced by InSynBio-AI Antibody Engineer Suite.
**审计追踪**：由 InSynBio-AI 抗体工程套件生成。
